Edwards Lifesciences Corp
XETRA:EWL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Edwards Lifesciences Corp
XETRA:EWL
|
US |
|
Aena SME SA
MAD:AENA
|
ES |
|
F
|
Fujitsu Ltd
XMUN:FUJ1
|
JP |
|
Central Asia Metals PLC
LSE:CAML
|
UK |
|
Remgro Ltd
OTC:RMGOF
|
ZA |
|
H
|
Heidelberg Materials AG
MIL:1HEI
|
DE |
|
M
|
Megawide Construction Corp
XPHS:MWIDE
|
PH |
|
Nestle SA
OTC:NSRGF
|
CH |
|
SoftBank Group Corp
TSE:9984
|
JP |
|
E
|
Estee Lauder Companies Inc
VSE:ESLA
|
US |
|
E
|
Exxon Mobil Corp
XBER:XONA
|
US |
|
B
|
Bank of America Corp
XBER:NCB
|
US |
|
S
|
Smurfit Kappa Group PLC
XBER:SK3
|
IE |
|
Indian Railway Finance Corp Ltd
NSE:IRFC
|
IN |
|
Sto SE & Co KgaA
LSE:0G5B
|
DE |
|
A
|
Amadeus IT Group SA
XMUN:AI3A
|
ES |
|
L
|
Lockheed Martin Corp
XMUN:LOM
|
US |
|
Sumitomo Electric Industries Ltd
F:SMO1
|
JP |
|
Thomson Reuters Corp
TSX:TRI
|
CA |
|
C
|
CITIC Ltd
OTC:CTPCY
|
CN |
|
A
|
Anglo American PLC
XBER:NGLB
|
UK |
|
F
|
Fiserv Inc
XBER:FIV
|
US |
Wall St Price Targets
EWL Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EWL is 85.55 EUR with a low forecast of 74.98 EUR and a high forecast of 100.88 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EWL's stock price target?
Price Target
85.55
EUR
According to Wall Street analysts, the average 1-year price target for EWL is 85.55 EUR with a low forecast of 74.98 EUR and a high forecast of 100.88 EUR.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 11%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is 15%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 27%.
